Altria Group
MONYSEUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $76.34 Prior regular-session close from the quote source.
- $75.53–$77.46 Regular-session low and high so far today.
- 7.0M Regular-session shares traded · Nov 11, 4:01 PM ET.
- Jan 28 projected Projected for 2027-01-28 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $54.70–$79.87 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own MO if Altria converts durable brand pricing power in combusted cigarettes into very strong cash flow, and the stock’s upside hinges on whether that cash can be sustained while new smoke‑free products scale and leverage is.
MO price history
Loading recent earnings…
Investment thesis
What must happen next
Altria’s pricing power, brand loyalty and low variable cost on combusted cigarettes will keep operating cash flow broadly stable at current multi‑billion levels, allowing continued dividends and buybacks unless a structural market share loss or regulatory cap occurs.StrengtheningMateriality: High
operating_cash_flow: $9,290,000,000 (FY2025). If OCF stays stable, shareholders can expect sustained dividend and buyback funding; if OCF collapses, the cash‑return thesis and valuation fail.
Watch: Rapid adult migration away from Altria’s combusted brands to independent e‑vapor or heated‑tobacco competitors that materially erode market share (a competitor‑led share shift).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
operating_cash_flow: $9,290,000,000 (FY2025).
Open source ↗Revenue stabilization depends on smoke‑free product revenue scaling faster than the decline in combusted cigarette volumes; absent that offset, consolidated revenue will continue its current downward trend.HoldingMateriality: High
revenue: $23,279,000,000 (FY2025). If smoke‑free growth outpaces combusted declines, reported revenue and underlying growth can stabilize and de‑risk the dividend; if not, headline revenue and long‑term growth will decline and multiple compression is likely.
Watch: Failure of Altria’s smoke‑free products to gain national adult smoker market share (market adoption risk / competitive product wins).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
revenue: $23,279,000,000 (FY2025).
Open source ↗Altria’s large liabilities and negative stockholders’ equity mean financial leverage is a constraint: a material cash‑flow shock or higher interest costs would force reduced buybacks/dividends or asset sales.StrengtheningMateriality: Medium
liabilities: $38,469,000,000 (FY2025, instant). High leverage amplifies downside: cash shocks translate quickly into cuts to shareholder returns or distress actions; managing liabilities is therefore necessary to preserve the equity story.
Watch: Large asset sales or monetizations (e.g., divestitures or equity monetizations) that materially reduce liabilities.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
liabilities: $38,469,000,000 (FY2025, instant).
Open source ↗Reported EPS is sensitive to share repurchases and non‑operating items; absent sustained operating income growth, EPS appreciation depends heavily on continued buybacks and capital returns.StrengtheningMateriality: Medium
eps_diluted: $4.12 (FY2025). If buybacks slow (or operating income drops), EPS will fall and the income‑return valuation weakens; conversely, aggressive buybacks can mask weak underlying operating performance.
Watch: Regulatory or credit covenant constraints that force a pause in repurchases (buyback constraint).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
eps_diluted: $4.12 (FY2025).
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Altria’s pricing power, brand loyalty and low variable cost on combusted cigarettes will keep operating cash flow broadly stable at current multi‑billion levels, allowing continued dividends and buybacks unless a structural market share loss or regulatory cap occurs. If OCF stays stable, shareholders can expect sustained dividend and buyback funding; if OCF collapses, the cash‑return thesis and valuation fail.
Revenue stabilization depends on smoke‑free product revenue scaling faster than the decline in combusted cigarette volumes; absent that offset, consolidated revenue will continue its current downward trend. If smoke‑free growth outpaces combusted declines, reported revenue and underlying growth can stabilize and de‑risk the dividend; if not, headline revenue and long‑term growth will decline and multiple compression is likely.
Altria’s large liabilities and negative stockholders’ equity mean financial leverage is a constraint: a material cash‑flow shock or higher interest costs would force reduced buybacks/dividends or asset sales. High leverage amplifies downside: cash shocks translate quickly into cuts to shareholder returns or distress actions; managing liabilities is therefore necessary to preserve the equity story.
Reported EPS is sensitive to share repurchases and non‑operating items; absent sustained operating income growth, EPS appreciation depends heavily on continued buybacks and capital returns. If buybacks slow (or operating income drops), EPS will fall and the income‑return valuation weakens; conversely, aggressive buybacks can mask weak underlying operating performance.
All standing thesis claims
Original report summary
Altria converts durable brand pricing power in combusted cigarettes into very strong cash flow, and the stock’s upside hinges on whether that cash can be sustained while new smoke‑free products scale and leverage is.
Bull case and bear case
Bull case and bear case for Altria Group
Where the evidence on Altria Group stands: Holding on the latest evidence (Oct 28, 2026). Of its 4 thesis points, 3 strengthening and 1 holding.
Bull case: what the evidence supports
Altria’s pricing power, brand loyalty and low variable cost on combusted cigarettes will keep operating cash flow broadly stable at current multi‑billion levels, allowing continued dividends and buybacks unless a structural market share loss or regulatory cap occurs.
Revenue stabilization depends on smoke‑free product revenue scaling faster than the decline in combusted cigarette volumes; absent that offset, consolidated revenue will continue its current downward trend.
Altria’s large liabilities and negative stockholders’ equity mean financial leverage is a constraint: a material cash‑flow shock or higher interest costs would force reduced buybacks/dividends or asset sales.
Reported EPS is sensitive to share repurchases and non‑operating items; absent sustained operating income growth, EPS appreciation depends heavily on continued buybacks and capital returns.
Bear case: what would count against it
Rapid adult migration away from Altria’s combusted brands to independent e‑vapor or heated‑tobacco competitors that materially erode market share (a competitor‑led share shift).
Failure of Altria’s smoke‑free products to gain national adult smoker market share (market adoption risk / competitive product wins).
Large asset sales or monetizations (e.g., divestitures or equity monetizations) that materially reduce liabilities.
Thesis-Break Engine
Thesis-break watch · Altria Group
Loading the break-condition record for Altria Group.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedEntered a material definitive agreement.
Altria Group filed an SEC 8-K on 2026-10-09: Entered a material definitive agreement. It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Altria Group filed an SEC 8-K on 2026-08-28: Director or principal officer change. It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Altria Group filed an SEC 8-K on 2026-07-30: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Rapid adult migration away from Altria’s combusted brands to independent e‑vapor or heated‑tobacco competitors that materially erode market share (a competitor‑led share shift).
- Failure of Altria’s smoke‑free products to gain national adult smoker market share (market adoption risk / competitive product wins).
- Large asset sales or monetizations (e.g., divestitures or equity monetizations) that materially reduce liabilities.
- Regulatory or credit covenant constraints that force a pause in repurchases (buyback constraint).
MO news
Loading headlines…
Financial statements
MO income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
MO: quick answers
- When does Altria Group (MO) report earnings next?
- Altria Group's next results are projected for January 28, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 29, 2026. Earnings calendar
- What is MO's short interest?
- As of October 30, 2026, 40.5M MO shares were sold short, 2.43% of its shares outstanding, up 1.7% from the count before. At the stock's average daily volume that is 4.6 days to cover. FINRA publishes the count twice a month. MO short interest history
- Have members of Congress traded MO?
- Reports made public in the last 90 days disclose 2 trades in MO by 2 filers: 1 purchase and 1 sale. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed MO trade
- Which well-known investors own MO?
- 2 of the 37 well-known funds tracked here reported MO shares in their latest 13F filings. By share of the fund's portfolio: Bridgewater Associates (Ray Dalio), 0.5%; Maverick Capital, 0.0%. Fund portfolios
MO in well-known investors’ portfolios
2 of 37 funds reported MO shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Ray DalioBridgewater Associates | 0.51% | $124M | +1.3% | Q2 2026 |
| Maverick Capital | 0.03% | $3.6M | −4.0% | Q2 2026 |
